Verywell Health on MSN12d
The 3 Types of Ovarian Cancer and How They Are Different
There are three main types of ovarian cancer: epithelial, germ cell, and stromal. Learn about each type’s defining ...
Clinical Trials Arena on MSN1d
FDA aligns with Imunon’s Phase III trial protocol for ovarian cancer treatment
Imunon is initiating sites for the trial and collaborating with investigators to commence participant enrolment.
HealthDay on MSN2d
CA-125 Levels Vary by Patient Race at Ovarian Cancer Diagnosis
Black and American Indian patients are less likely to have elevated cancer antigen (CA)-125 levels at ovarian cancer ...
IMUNON Finalizes Phase 3 Study Design with FDA for IMNN-001 in Newly Diagnosed Advanced Ovarian Cancer
First and only immunotherapy to show meaningful overall survival benefit in a Phase 2 trial in patients with advanced ovarian cancer Initiation ...
CURE2d
First Patient Dosed in Phase 3 Trial of IBI354 for Ovarian Cancer
The first patient was dosed in a phase 3 trial of IBI354 for platinum-resistant ovarian cancer with HER2 expression.
Cancer Therapy Advisor8d
Pembrolizumab-Olaparib Maintenance Improves PFS in Advanced Ovarian Cancer
Patients in the pembrolizumab-olaparib arm had clinically meaningful improvements in PFS over patients in the control arm.
GEN - Genetic Engineering and Biotechnology News12d
Ovarian Cancer Linked to High-Risk Progenitor Cells in Fallopian Tube Stroma
Researcher suggests compounds secreted by high-risk MSCs that are detectable in the bloodstream could act as biomarkers for ...
Pharmabiz1d
Innovent Biologics begins patient dosing in phase 3 study of IBI354 for platinum-resistant ovarian cancer
Innovent Biologics begins patient dosing in phase 3 study of IBI354 for platinum-resistant ovarian cancer: San Francisco Tuesday, March 25, 2025, 18:00 Hrs [IST] Innovent Biologic ...